Pfizer Recalls More Lipitor Over Odors
From UPI Health News (Business) (October 30, 2010)
Pfizer is recalling yet more Lipitor shipments over reports of unpleasant odors, the drug company said.
The New York company announced Friday a recall of about 38,000 bottles of 40-milligram tablets distributed in the United States, The Wall Street Journal reported. Pfizer recalled about 332,000 bottles of the cholesterol-lowering medicine in August.
The company linked the uncharacteristic smell to the bottles, which it said were supplied by an outside manufacturer in Puerto Rico.
Pfizer warned there may be more recalls because products made before production procedures were fixed could still be on the market.
The company said Friday the odor is consistent with the presence of 2,4,6 tribromoanisole, or TBA, which was found at a very low level in a sample bottle during the probe that led to the first recall. TBA is used as a wood preservative on pallets.
Pfizer spokesman Ray Kerins said the company has taken steps to cut risk of TBA contamination, including requiring the use of plastic pallets to transport empty bottles.
Lipitor is the best-selling prescription drug in the
Posted: November 2010